Microbiology

University of Texas has spent seven years developing a nasal spray vaccine against Ebola

DISPATCHES FROM AAPS 2014

Ebola nasal vaccine under threat as funding runs dry

By Dan Stanton

Lack of funding is threatening development of a nasal spray vaccine shown to provide long-term protection for non-human primates against the Ebola virus, the lead researcher told this publication in an exclusive interview.

 Spain announced that it imported a few doses of Mapp Biopharmaceutical’s ZMapp to treat a priest who was brought from Liberia to Madrid

Biopharma companies race to develop Ebola vaccine

By Zachary Brennan

As the death toll from the world’s most expansive Ebola outbreak nears 1,000, multiple companies are stepping up efforts to bring antibodies and other vaccines to human trials, though none seem likely to be ready until 2015 at the earliest.

PPD expands in Brussels and Singapore

PPD Expands Central Lab Services in Brussels, Singapore

By Zachary Brennan

PPD has expanded its central lab testing services at its Brussels and Singapore labs and will offer additional services in microbiology, peripheral blood mononuclear cell and molecular pathology services.